FDA Inspection
Agnitio IncAgnitio Inc – FDA Inspection, Jun 4, 2021
Record Details
This FDA Inspection record concerns Agnitio Inc, with an inspection on June 4, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Agnitio Inc
- Inspection Date
- June 4, 2021
- Product Type
- Drugs
View Company Profile
ID · d19d5009-9492-4a21-8033-cd779e5d70df
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1146649
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Agnitio Inc
3| Date | Classification | Office | Project area |
|---|---|---|---|
| November 21, 2025 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 9, 2018 | VAI | Minneapolis District Office | Generic Drug Evaluation |
| July 19, 2018 | VAI | Minneapolis District Office | Generic Drug Evaluation |
Other documents for Agnitio Inc
- FDA Inspection 1295362 - 2025-11-21
- FDA Inspection 1071299 - 2018-11-09
- FDA Inspection 1059372 - 2018-07-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.